Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  St. Jude Medical, Inc.    STJ

SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

St. Jude Medical, Inc. : StockCall Scrutinizes STJ, HOLX, NAVB, EW, and RMD

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 02:35pm CET

StockCall.com Provides Stock Research on St. Jude Medical Inc., Hologic Inc., Navidea Biopharmaceuticals Inc., Edwards Lifesciences Corp., and ResMed Inc.

New York City, New York -- (May 17, 2013)

The Affordable Care Act (ACA), which is the biggest overhaul of the healthcare industry in decades, has generally been welcomed by the healthcare industry. The industry believes that the increase in the number of insured individuals due to the ACA will ultimately benefit it. However, medical appliances & equipment makers have been the most vocal critics of the reform. This is because medical appliances & equipment are required to pay a 2.3% tax on gross U.S. sales of medical devices. The industry believes that this will result in higher costs and hurt innovation. On Thursday, shares of medical appliances & equipment companies ended mostly lower, tracking losses in the broad market. Among the major movers in the sector were St. Jude Medical Inc. (NYSE: STJ), Hologic Inc. (NASDAQ: HOLX), Navidea Biopharmaceuticals Inc. (AMEX: NAVB), Edwards Lifesciences Corp. (NYSE: EW), and ResMed Inc. (NYSE: RMD). StockCall reviewed the medical appliances & equipment industry and chose STJ, HOLX, NAVB, EW, and RMD for its technical coverage. These free reports can be seen for free at

www.stockcall.com/signup

Shares of St. Jude Medical Inc. edged higher on Thursday, touching a 52-week high of $47.14. The stock closed 0.54% higher at $46.82 on above average volume of 3.43 million. St. Jude Medical?s shares have gained more than 3.50% in the last three trading sessions. The stock has seen a series of highs over the past two weeks which is a bullish signal. Despite the challenges facing the industry, shares of STJ have gained more than 30.30% so far in 2013. Download the free research on STJ by signing up now at

www.StockCall.com/STJ051713.pdf

Shares of Hologic Inc. fell in trading yesterday, extending its losses from previous trading sessions. The stock ended the day 1.04% lower at $20.87 on volume of 2.12 million, taking its losses in the last three sessions to more than 2.10%. Year-to-date, shares of HOLX have gained 4.30% as compared to a growth of more than 15.70% for the S&P 500. The stock is currently trading 12.90% below its 52-week high. Shares are currently trading below their 50-day and 200-day moving averages which is a bearish signal. Register for today?s free analysis on HOLX at

www.StockCall.com/HOLX051713.pdf

Navidea Biopharmaceuticals Inc.?s shares fell sharply on Thursday. The stock finished the day 2.49% lower at $2.35 on volume of 607,040. Navidea?s shares are currently trading close to their 52-week low of $2.14. The stock has fallen nearly 17% so far this year even as the broad market has rallied. The company?s shares are currently trading well below their 50-day and 200-day moving averages. Free report on NAVB can be accessed by registering at

www.StockCall.com/NAVB051713.pdf

Shares of Edwards Lifesciences Corp. struggled in trading yesterday. The stock traded between $67.75 and $70.85 before finishing the day 3.56% lower at $68.81 on above average volume of 2 million. Despite the sharp decline on Thursday, Edwards Lifesciences? shares are up nearly 1.90% in the last three trading sessions. The stock had seen a series of highs this week before seeing a pullback yesterday. Shares of the company have fallen nearly 24% so far in 2013.Register withStockCall and download the research on EW for free at

www.StockCall.com/EW051713.pdf

Shares of ResMed Inc. edged lower on Thursday. The stock closed 1.46% lower at $49.80 on volume of 1.05 million which is in-line with the daily average. Despite the pullback, ResMed?s shares are currently trading close to their 52-week high of $51.40. The stock has outperformed the broad market this year, gaining more than 20.20%. Shares of the company are also trading well above their 50-day and 200-day moving averages. Read the full free research on RMD by signing up to StockCall at

www.StockCall.com/RMD051713.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

www.stockcall.com

Contact Person:

William T. Knight

Email: info@stockcall.com

Contact Number: (646) 396-9857 (9:00 am EST ? 01:30 pm EST)


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ST. JUDE MEDICAL, INC.
01/19 ST JUDE MEDICAL : Patent Issued for Simulated Environment for Transcatheter Hear..
01/18 ST JUDE MEDICAL : $27,244 Federal Contract Awarded to t. Jude Medical
01/12 ST JUDE MEDICAL : Patent Issued for Catheter with a Mechanism for Omni-Direction..
01/12 ST JUDE MEDICAL : Trademark Application for "ENDURANCE" Filed by St. Jude Medica..
01/12 ST JUDE MEDICAL : Patent Issued for Delivery System Deflection Mechanism (USPTO ..
01/12 ST JUDE MEDICAL : Flawed implant shows that medical devices are vulnerable to ha..
01/11 CORRECTION : Correction for Wednesday, Jan. 11, 2017
01/10 ST JUDE MEDICAL : FDA says St. Jude heart devices vulnerable to hacking
01/09 ST JUDE MEDICAL : Contract award - 65-- va263-17-p-1504 pros v23 618 272784 card..
01/07 ST JUDE MEDICAL : Federal Contracts Awarded to Companies in Minnesota (Jan. 7)
More news
Sector news : Medical Devices & Implants
01/17DJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
01/17DJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
01/17DJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Devices & Implants
News from SeekingAlpha
01/11 Medtech Mergers And Acquisitions Regresses To The Mean In 2016
01/09 ABBOTT CLOSES ST. JUDE MEDICAL DEAL : Good For Shareholders?
01/04 Political Ructions, Poor Deal-Making And Scandal - A Bad Year For Big-Cap Med..
01/04 Time To Rush For The Exit?
01/03 IDEXX Labs to join S&P 500, Chemours bumps up to S&P MidCap 400
Advertisement
Financials ($)
More Financials
Chart ST. JUDE MEDICAL, INC.
Duration : Period :
St. Jude Medical, Inc. Technical Analysis Chart | STJ | US7908491035 | 4-Traders
Full-screen chart
Technical analysis trends ST. JUDE MEDICAL,...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael T. Rousseau President, Chief Executive Officer & Director
Daniel J. Starks Executive Chairman
Scott P. Thome Vice President-Global Operations & Supply Chain
Donald J. Zurbay Chief Financial Officer & Vice President
Mark D. Carlson Chief Medical Officer & VP-Global Clinical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ST. JUDE MEDICAL, INC.0.79%0
STRYKER CORPORATION1.62%45 589
SMITH & NEPHEW PLC-1.31%13 025
WRIGHT MEDICAL GROUP N..8.31%2 571
GLAUKOS CORP12.07%1 290
OSSTEM IMPLANT CO LTD--.--%718
More Results